艾迪注射液联合其他疗法治疗妇科恶性肿瘤的研究进展综述
Review of Research Progress on Aidi Injection Combined with Other Therapies in the Treatment of Gynecologic Malignancies

背景：艾迪注射液作为传统的中药制剂，含斑蝥、人参、黄芪、刺五加等成分，近年来在妇科恶性肿瘤治疗领域应用日益广泛。目的：综述艾迪注射液联合其他疗法(化疗、放化疗、新辅助化疗与间隔性减灭术)及联合孕激素类药物(甲地孕酮)在妇科恶性肿瘤治疗中的研究进展，评估其疗效与安全性。方法：通过回顾相关科学研究与临床试验，分析艾迪注射液的作用机制，包括免疫调控、诱导肿瘤细胞凋亡、抗血栓等，并探讨其与多种治疗手段的联合应用效果。结论：艾迪注射液在联合治疗中展现出良好疗效与安全性，能够有效改善妇科恶性肿瘤患者的临床症状，显著提升患者的生存质量。
Background: As a traditional Chinese medicine preparation, Aidi Injection contains ingredients such as Mylabris, Ginseng, Astragalus membranaceus, and Acanthopanax senticosus. It has been increasingly widely used in the treatment of gynecological malignant tumors in recent years. Objective: This paper aims to review the research progress of Aidi Injection combined with other therapies (chemotherapy, chemoradiotherapy, neoadjuvant chemotherapy and interval debulking surgery) and combined with progestin drugs (megestrol acetate) in the treatment of gynecological malignant tumors, and evaluate its efficacy and safety. Method: By reviewing relevant scientific research and clinical trials, the mechanism of action of Aidi Injection was analyzed, including immune regulation, induction of tumor cell apoptosis, and antithrombosis, and the combined application effects with various treatment methods were discussed. Conclusion: Aidi Injection shows good efficacy and safety in combination therapy, which can effectively improve the clinical symptoms of patients with gynecological malignant tumors and significantly improve the quality of life of patients.